Verastem Inc. to Participate in Cantor Global Healthcare Conference 2025
I'm PortAI, I can summarize articles.
Verastem Inc., a biopharmaceutical company focused on RAS/MAPK pathway-driven cancers, will participate in the Cantor Global Healthcare Conference 2025. The management team is scheduled to present during a fireside chat on September 3 at 3:55 pm ET. This announcement was generated by Public Technologies and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments